Why the study?
Do new oral anticoagulants have different pleiotropic effects on vascular calcification and atherosclerosis compared to vitamin K antagonists?
Do new oral anticoagulants have different pleiotropic effects on vascular calcification and atherosclerosis compared to vitamin K antagonists?
This review highlights that while vitamin K antagonists may induce vascular calcification and accelerate plaque vulnerability in animal models, direct oral anticoagulants may attenuate atherosclerosis, suggesting important pleiotropic differences.
No takes yet. Share an insight, caveat, or question.
Preclinical differences may influence anticoagulant selection in vascular disease; leaves open translation to human outcomes and trials.
Spronk et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: